266 related articles for article (PubMed ID: 33555556)
1. Molecular dynamics, residue network analysis, and cross-correlation matrix to characterize the deleterious missense mutations in GALE causing galactosemia III.
Kumar SU; Sankar S; Kumar DT; Younes S; Younes N; Siva R; Doss CGP; Zayed H
Cell Biochem Biophys; 2021 Jun; 79(2):201-219. PubMed ID: 33555556
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dynamics of wildtype and V94M human UDP-galactose 4-epimerase-A computational perspective on severe epimerase-deficiency galactosemia.
Timson DJ; Lindert S
Gene; 2013 Sep; 526(2):318-24. PubMed ID: 23732289
[TBL] [Abstract][Full Text] [Related]
3. In silico prediction of the effects of mutations in the human UDP-galactose 4'-epimerase gene: towards a predictive framework for type III galactosemia.
McCorvie TJ; Timson DJ
Gene; 2013 Jul; 524(2):95-104. PubMed ID: 23644136
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of mutations in UDP-galactose-4-epimerase (GALE) associated with galactosemia in Korean patients using mammalian GALE-null cells.
Bang YL; Nguyen TT; Trinh TT; Kim YJ; Song J; Song YH
FEBS J; 2009 Apr; 276(7):1952-61. PubMed ID: 19250319
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of UDP-galactose-4-epimerase (GALE) deficiency galactosemia in Korean patients.
Park HD; Park KU; Kim JQ; Shin CH; Yang SW; Lee DH; Song YH; Song J
Genet Med; 2005; 7(9):646-9. PubMed ID: 16301867
[TBL] [Abstract][Full Text] [Related]
6. The metastability of human UDP-galactose 4'-epimerase (GALE) is increased by variants associated with type III galactosemia but decreased by substrate and cofactor binding.
Pey AL; Padín-Gonzalez E; Mesa-Torres N; Timson DJ
Arch Biochem Biophys; 2014 Nov; 562():103-14. PubMed ID: 25150110
[TBL] [Abstract][Full Text] [Related]
7. Human UDP-galactose 4' epimerase (GALE) gene and identification of five missense mutations in patients with epimerase-deficiency galactosemia.
Maceratesi P; Daude N; Dallapiccola B; Novelli G; Allen R; Okano Y; Reichardt J
Mol Genet Metab; 1998 Jan; 63(1):26-30. PubMed ID: 9538513
[TBL] [Abstract][Full Text] [Related]
8. UDP-hexose 4-epimerases: a view on structure, mechanism and substrate specificity.
Beerens K; Soetaert W; Desmet T
Carbohydr Res; 2015 Sep; 414():8-14. PubMed ID: 26162744
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of missense mutations in galactokinase 1 (GALK1) leading to galactosemia type-2.
P S; Ebrahimi EA; Ghazala SA; D TK; R S; Priya Doss C G; Zayed H
J Cell Biochem; 2018 Sep; 119(9):7585-7598. PubMed ID: 29893426
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of disease-causing mutations in human UDP-galactose 4-epimerase.
Timson DJ
FEBS J; 2005 Dec; 272(23):6170-7. PubMed ID: 16302980
[TBL] [Abstract][Full Text] [Related]
11. Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase.
Quimby BB; Alano A; Almashanu S; DeSandro AM; Cowan TM; Fridovich-Keil JL
Am J Hum Genet; 1997 Sep; 61(3):590-8. PubMed ID: 9326324
[TBL] [Abstract][Full Text] [Related]
12. Mediators of galactose sensitivity in UDP-galactose 4'-epimerase-impaired mammalian cells.
Schulz JM; Ross KL; Malmstrom K; Krieger M; Fridovich-Keil JL
J Biol Chem; 2005 Apr; 280(14):13493-502. PubMed ID: 15701638
[TBL] [Abstract][Full Text] [Related]
13. Analysis of UDP-galactose 4'-epimerase mutations associated with the intermediate form of type III galactosaemia.
Chhay JS; Vargas CA; McCorvie TJ; Fridovich-Keil JL; Timson DJ
J Inherit Metab Dis; 2008 Feb; 31(1):108-16. PubMed ID: 18188677
[TBL] [Abstract][Full Text] [Related]
14. Epimerase-deficiency galactosemia is not a binary condition.
Openo KK; Schulz JM; Vargas CA; Orton CS; Epstein MP; Schnur RE; Scaglia F; Berry GT; Gottesman GS; Ficicioglu C; Slonim AE; Schroer RJ; Yu C; Rangel VE; Keenan J; Lamance K; Fridovich-Keil JL
Am J Hum Genet; 2006 Jan; 78(1):89-102. PubMed ID: 16385452
[TBL] [Abstract][Full Text] [Related]
15. Altered cofactor binding affects stability and activity of human UDP-galactose 4'-epimerase: implications for type III galactosemia.
McCorvie TJ; Liu Y; Frazer A; Gleason TJ; Fridovich-Keil JL; Timson DJ
Biochim Biophys Acta; 2012 Oct; 1822(10):1516-26. PubMed ID: 22613355
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning, characterization, and mapping of a full-length cDNA encoding human UDP-galactose 4'-epimerase.
Daude N; Gallaher TK; Zeschnigk M; Starzinski-Powitz A; Petry KG; Haworth IS; Reichardt JK
Biochem Mol Med; 1995 Oct; 56(1):1-7. PubMed ID: 8593531
[TBL] [Abstract][Full Text] [Related]
17. Characterization of hypothetical protein VNG0128C from Halobacterium NRC-1 reveals GALE like activity and its involvement in Leloir pathway of galactose metabolism.
Reshma SV; Sathyanarayanan N; Nagendra HG
J Biomol Struct Dyn; 2015; 33(8):1743-55. PubMed ID: 25397923
[TBL] [Abstract][Full Text] [Related]
18. The structural basis of substrate promiscuity in UDP-hexose 4-epimerase from the hyperthermophilic Eubacterium Thermotoga maritima.
Shin SM; Choi JM; di Luccio E; Lee YJ; Lee SJ; Lee SJ; Lee SH; Lee DW
Arch Biochem Biophys; 2015 Nov; 585():39-51. PubMed ID: 26344854
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of the K257R and G319E-hGALE alleles found in patients with ostensibly peripheral epimerase deficiency galactosemia.
Wasilenko J; Lucas ME; Thoden JB; Holden HM; Fridovich-Keil JL
Mol Genet Metab; 2005 Jan; 84(1):32-8. PubMed ID: 15639193
[TBL] [Abstract][Full Text] [Related]
20.
Marín-Quílez A; Di Buduo CA; Benito R; Balduini A; Rivera J; Bastida JM
Platelets; 2023 Dec; 34(1):2176699. PubMed ID: 36846897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
